Anna Glaser

2.7k total citations
56 papers, 1.5k citations indexed

About

Anna Glaser is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Anna Glaser has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 17 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Anna Glaser's work include Multiple Sclerosis Research Studies (20 papers), Alzheimer's disease research and treatments (12 papers) and Amyotrophic Lateral Sclerosis Research (6 papers). Anna Glaser is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Alzheimer's disease research and treatments (12 papers) and Amyotrophic Lateral Sclerosis Research (6 papers). Anna Glaser collaborates with scholars based in Sweden, United Kingdom and United States. Anna Glaser's co-authors include Jan Hillert, Rolf Ohlsson, Holger Luthman, Susan Pfeifer‐Ohlsson, Lars Holmgren, Joakim Galli, Hossein Fakhrai-Rad, Ali Manouchehrinia, Howard J. Jacob and Andrius Kavaliūnas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The EMBO Journal.

In The Last Decade

Anna Glaser

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Glaser Sweden 22 530 470 352 240 221 56 1.5k
Jing‐Ping Lin United States 21 788 1.5× 311 0.7× 263 0.7× 324 1.4× 137 0.6× 52 2.1k
Ekaterini Tsilou United States 22 948 1.8× 226 0.5× 245 0.7× 148 0.6× 348 1.6× 36 2.2k
M. A. Kelly United Kingdom 21 299 0.6× 520 1.1× 521 1.5× 121 0.5× 255 1.2× 39 1.5k
Ana Silva Portugal 24 560 1.1× 598 1.3× 106 0.3× 224 0.9× 362 1.6× 110 1.9k
Marie‐Claude Babron France 28 428 0.8× 203 0.4× 877 2.5× 173 0.7× 336 1.5× 94 2.2k
Jia Nee Foo Singapore 20 896 1.7× 151 0.3× 559 1.6× 200 0.8× 264 1.2× 71 2.1k
Thomas Masterman Sweden 24 480 0.9× 900 1.9× 288 0.8× 135 0.6× 291 1.3× 51 2.2k
Syed A. Morshed United States 26 520 1.0× 276 0.6× 202 0.6× 146 0.6× 150 0.7× 65 2.3k
Lawrence Charnas United States 27 1.2k 2.2× 378 0.8× 724 2.1× 446 1.9× 96 0.4× 54 2.7k
Hannu Tuominen Finland 20 411 0.8× 370 0.8× 98 0.3× 229 1.0× 194 0.9× 72 1.7k

Countries citing papers authored by Anna Glaser

Since Specialization
Citations

This map shows the geographic impact of Anna Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Glaser more than expected).

Fields of papers citing papers by Anna Glaser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Glaser. The network helps show where Anna Glaser may publish in the future.

Co-authorship network of co-authors of Anna Glaser

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Glaser. A scholar is included among the top collaborators of Anna Glaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Glaser. Anna Glaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkowitz, Héloïse, et al.. (2023). Organizing Commons in Time and Space with Framapads: Feedback from an Open Community. 2(1). 6–11. 1 indexed citations
2.
He, Anna, Ali Manouchehrinia, Anna Glaser, et al.. (2023). Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context. JAMA Network Open. 6(9). e2334675–e2334675. 5 indexed citations
3.
Teni, Fitsum Sebsibe, Alejandra Machado, Anna He, et al.. (2022). Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden. Multiple Sclerosis and Related Disorders. 69. 104456–104456. 2 indexed citations
4.
Bedri, Sahl Khalid, Ola B. Nilsson, Katharina Fink, et al.. (2019). Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment. PLoS ONE. 14(5). e0217208–e0217208. 11 indexed citations
5.
Manouchehrinia, Ali, Helga Westerlind, Elaine Kingwell, et al.. (2017). Age Related Multiple Sclerosis Severity Score: Disability ranked by age. Multiple Sclerosis Journal. 23(14). 1938–1946. 102 indexed citations
6.
Bedri, Sahl Khalid, Katharina Fink, Ali Manouchehrinia, et al.. (2017). Multiple sclerosis treatment effects on plasma cytokine receptor levels. Clinical Immunology. 187. 15–25. 5 indexed citations
7.
Kavaliūnas, Andrius, Ali Manouchehrinia, Virginija Danylaité Karrenbauer, et al.. (2017). Income in Multiple Sclerosis Patients with Different Disease Phenotypes. PLoS ONE. 12(1). e0169460–e0169460. 13 indexed citations
8.
Kavaliūnas, Andrius, Petter Tinghög, Anna Glaser, et al.. (2015). Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients. PLoS ONE. 10(12). e0145435–e0145435. 32 indexed citations
9.
Tinghög, Petter, Charlotte Björkenstam, John Carstensen, et al.. (2014). Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study. BMC Neurology. 14(1). 117–117. 24 indexed citations
10.
Ingvast, Sofie, Toshifumi Matsui, Stefanie H. Freeman, et al.. (2009). No Evidence of PGRN or MAPT Gene Dosage Alterations in a Collection of Patients with Frontotemporal Lobar Degeneration. Dementia and Geriatric Cognitive Disorders. 28(5). 456–460. 4 indexed citations
11.
Blom, E., Vilmantas Giedraitis, Sampath Arepalli, et al.. (2009). Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairs. BMC Medical Genetics. 10(1). 122–122. 3 indexed citations
12.
Giedraitis, Vilmantas, Anna Glaser, Timo Sarajärvi, et al.. (2009). CALHM1 P86L polymorphism does not alter amyloid-β or tau in cerebrospinal fluid. Neuroscience Letters. 469(2). 265–267. 9 indexed citations
13.
Viitanen, Matti, Hannu Kalimo, Lars Lannfelt, et al.. (2008). The tau S305S mutation causes frontotemporal dementia with parkinsonism. European Journal of Neurology. 15(2). 156–161. 22 indexed citations
14.
Holmans, Peter, Sampath Arepalli, Omanma Adighibe, et al.. (2007). Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(6). 778–783. 7 indexed citations
15.
Giedraitis, Vilmantas, Mattias Hedlund, Erik Blom, et al.. (2006). New Alzheimer's disease locus on chromosome 8. Journal of Medical Genetics. 43(12). 931–935. 15 indexed citations
16.
Kilander, Lena, et al.. (2004). Clinical and Molecular Aspects of Frontotemporal Dementia. Neurodegenerative Diseases. 1(4-5). 218–224. 7 indexed citations
17.
Rüther, E. & Anna Glaser. (2000). A Prospective PMS Study to Validate the Sensitivity for Change of the D-Scale in Advanced Stages of Dementia Using the NMDA-Antagonist Memantine. Pharmacopsychiatry. 33(3). 103–108. 23 indexed citations
18.
Koike, George, P. van Vooren, Masahide Shiozawa, et al.. (1996). Genetic Mapping and Chromosome Localization of the Rat Mitochondrial Glycerol-3-phosphate Dehydrogenase Gene, a Candidate for Non-Insulin-Dependent Diabetes Mellitus. Genomics. 38(1). 96–99. 14 indexed citations
19.
Walsh, Colum P., Anna Glaser, Reinald Fundele, et al.. (1994). The non-viability of uniparental mouse conceptuses correlates with the loss of the products of imprinted genes. Mechanisms of Development. 46(1). 55–62. 54 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing‐Ping Lin Breakdown of academic impact, for papers by Ekaterini Tsilou Breakdown of academic impact, for papers by M. A. Kelly Breakdown of academic impact, for papers by Ana Silva Breakdown of academic impact, for papers by Marie‐Claude Babron Breakdown of academic impact, for papers by Jia Nee Foo Breakdown of academic impact, for papers by Thomas Masterman Breakdown of academic impact, for papers by Syed A. Morshed Breakdown of academic impact, for papers by Lawrence Charnas Breakdown of academic impact, for papers by Hannu Tuominen
Rankless by CCL
2026